Low-quality evidence found to support use of cannabinoids for CINV
the ONA take:
According to a study published in the Journal of the American Medical Association, researchers have found moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and lower-quality evidence to support their use to treat chemotherapy-induced nausea and vomiting (CINV).
Cannabinoids are the active chemical compounds in marijuana.
For the study, researchers analyzed data from 79 trials that included 6,462 participants. Results of the meta-analysis showed that there was moderate-quality evidence to support the use of cannabinoids for the treatment of cancer pain. Researchers found low-quality evidence suggesting that cannabinoids improve CINV and very low-quality evidence to improve anxiety.
In regard to safety, cannabinoid use was associated with an increased risk of confusion, disorientation, dizziness, drowsiness, dry mouth, euphoria, fatigue, hallucination, loss of balance, nausea, and somnolence.
Moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- Distress Management Tool Gets an Update, Patient Version
- PSA Screening Rates Level Off in United States
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|